Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,605.86 +461.01 (+0.73%) CMC Crypto 200
1,392.86 -3.67 (-0.26%)
BioMarin Pharmaceutical Inc. (0HNC.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:05PM BST
| Previous close | 83.32 |
| Open | 82.35 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 81.50 - 82.94 |
| 52-week range | 76.29 - 99.65 |
| Volume | |
| Avg. volume | 5,967 |
| Market cap | 148.431M |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 3.79 |
| EPS (TTM) | 0.22 |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GuruFocus.comBeyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
Insider MonkeyBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
Simply Wall St.BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
BioMarin Pharmaceutical ( NASDAQ:BMRN ) First Quarter 2024 Results Key Financial Results Revenue: US$648.8m (up 8.8...
© 2024 Yahoo. All rights reserved.